Most Popular Brands: Neurontin, Gabatin, APO-Gabapentin (Show all)
Generic Name: Gabapentin
Gabapentin is an anticonvulsant medication used as an adjunct treatment for partial seizures and for the management of postherpetic neuralgia. Off label it is used for the treatment of social phobia and chronic pain.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Fibromyalgia | 181 |
|
|
|
|
|
47 |
| Nerve pain (neuropathic pain) | 45 |
|
|
|
|
10 | |
| Pain | 40 |
|
|
|
|
|
14 |
| Aching/Burning/Throbbing/Buzzing tendon body pain | 36 |
|
|
|
|
|
10 |
| Muscle Pain | 19 |
|
|
|
|
6 | |
| Neuralgia | 19 |
|
|
|
6 |
See all 390 patients currently taking Gabapentin
Mouse over the table for more information
Top 10 dosages based on patients currently taking Gabapentin. See all 35 dosages ►
| 100 mg all the time (24/7) | 100mg as needed | 1600 mg all the time (24/7) | 200 mg all the time (24/7) | 300 mg as needed | 300mg as needed | 4 100mg as needed | 600 mg all the time (24/7) | 600 mg as needed | 600mg as needed | 800 mg all the time (24/7) | 900 mg all the time (24/7) | 25 mg daily | 100 mg daily | 200 mg daily | 300 mg daily | 400 mg daily | 500 mg daily | 600 mg daily | 700 mg daily | 800 mg daily | 900 mg daily | 1200 mg daily | 1500 mg daily | 1600 mg daily | 1800 mg daily | 2000 mg daily | 2100 mg daily | 2400 mg daily | 2700 mg daily | 2800 mg daily | 3000 mg daily | 3200 mg daily | 3300 mg daily | 3600 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
24
|
20
|
78
|
7
|
1
|
54
|
1
|
12
|
77
|
28
|
1
|
7
|
31
|
1
|
2
|
21
|
12
|
2
|
2
|
2
|
1
|
12
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
27 | 43% |
|
|
Side effects too severe
|
20 | 32% |
|
|
Other
|
8 | 13% |
|
|
Doctor's advice
|
7 | 11% |
|
|
Expense
|
4 | 6% |
|
|
Course of treatment ended
|
4 | 6% |
|
|
Personal research
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.